Trends in Cardiovascular Medicine
Volume 17, Issue 3 , Pages 91-96, April 2007

Glycogen Synthase Kinase-3β—Actively Inhibiting Hypertrophy

  • Risto Kerkelä
  • ,
  • Kathleen Woulfe
  • ,
  • Thomas Force

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Dr. Thomas Force, Center for Translational Medicine, Jefferson Medical College, 1025 Walnut St, College Bldg Room 316, Philadelphia, PA 19107, USA

Center for Translational Medicine, Jefferson Medical College, Philadelphia, PA 19107, USA

A number of signaling pathways are involved in the regulation of cardiac hypertrophy and remodeling. One that serves as an integrator of upstream inputs, and as a transducer to downstream effectors, is the protein kinase, glycogen synthase kinase-3β. In this work we review the role of this putative “nodal point” in the response of the heart to growth stimuli, both physiologic and pathologic.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(07)00043-6

doi:10.1016/j.tcm.2007.01.004

Trends in Cardiovascular Medicine
Volume 17, Issue 3 , Pages 91-96, April 2007